title: High-dose tissue plasminogen activator, topical nitroglycerin, and heparin for severe ischemic injury in a neonate.
authors: Department of Pediatrics, Tulane Hospital for Children, New Orleans, LA 70112, USA. oakingbo@tulane.edu
authors: Olugbenga
authors: O
authors: Akingbola
authors: Dinesh
authors: D
authors: Singh
authors: Rodney
authors: R
authors: Steiner
authors: Edwin
authors: E
authors: Frieberg
authors: Matei
authors: M
authors: Petrescu
mesh_terms: D000279:Administration, Cutaneous; D002404:Catheterization / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005263:Femoral Artery / Q000293:injuries; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D007262:Infusions, Intravenous; D015278:Intensive Care Units, Pediatric; D007511:Ischemia / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D007866:Leg / Q000098:blood supply*; D008297:Male; D005996:Nitroglycerin / Q000008:administration & dosage*; D012720:Severity of Illness Index; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014034:Toes / Q000098:blood supply; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D014665:Vasodilator Agents; D006493:Heparin; D010959:Tissue Plasminogen Activator; D005996:Nitroglycerin